Thus, Fra-2 silencing is accompanied by upregulation of p53 and concomitant downmodulation of c-Fos, c-Jun and the viral oncoproteins E6/E7 in HPV + HNSCC cells. The gene discussed is FOS; the disease is head and neck squamous cell carcinoma.